Our Pricing

UK Mounjaro Prices + £124.99 off Discount Code WEIGHTLOSSNEW

Published on: June 03, 2026

Searching for transparent mounjaro price uk online pharmacy information? At Cured Pharmacy, Mounjaro (tirzepatide) KwikPen injections start from £124.99, with upfront pricing shown before your free clinical consultation. Our UK-registered prescribers assess every patient individually, ensuring safe, genuine treatment delivered discreetly to your door.

How Mounjaro Tirzepatide Works for Weight Loss

Mounjaro contains tirzepatide, the first dual GIP/GLP-1 receptor agonist licensed by the MHRA for weight management in the UK [1]. Unlike single-pathway treatments, tirzepatide activates both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors simultaneously, regulating appetite, slowing gastric emptying, and improving insulin sensitivity.

In the SURMOUNT-1 clinical trial, adults with obesity achieved an average weight reduction of 22.5% over 72 weeks on the 15mg maintenance dose — the highest efficacy observed in any weight loss medication trial to date [1]. Participants also reported improved cardiometabolic markers, including reduced waist circumference and better glycaemic control.

Mounjaro is administered as a once-weekly subcutaneous injection using a pre-filled KwikPen device. Dosing begins at 2.5mg weekly for four weeks, then escalates gradually to minimise gastrointestinal side effects, with maintenance doses ranging from 5mg to 15mg depending on individual response and tolerability [2].

Mounjaro Price UK: What You'll Pay at Cured Pharmacy

At Cured Pharmacy, Mounjaro pricing starts from £124.99 per prescription, with transparent costs displayed before you begin your online consultation. This includes your medication, clinical assessment by a UK-registered prescriber, and discreet home delivery. There are no hidden consultation fees or surprise charges at checkout.

Use discount code WEIGHTLOSSNEW at checkout to receive £135.00 off your first order, making Mounjaro more accessible for patients beginning their weight management journey. This offer applies to new patients completing their first clinical assessment with our team.

Your final prescription cost depends on the dose your prescriber determines is clinically appropriate based on your medical history, current medications, and weight loss goals. All pricing is confirmed upfront, so you'll know exactly what you're paying before proceeding.

Why Prices Vary Across UK Pharmacies

Mounjaro pricing across UK online pharmacies reflects differences in operational models, consultation structures, and supply arrangements. At Cured Pharmacy, our superintendent pharmacist Tarun Kumar (GPhC 2233073) oversees a streamlined service that keeps costs competitive without compromising clinical safety or medication authenticity.

We guarantee 100% genuine UK-licensed Mounjaro sourced directly through regulated pharmaceutical wholesalers. Every pen is stored in temperature-controlled facilities and dispatched in compliant cold-chain packaging to maintain medication integrity throughout delivery.

Comparing Mounjaro to Other Weight Loss Treatments

The UK weight loss medication landscape includes several prescription options, each with distinct mechanisms, dosing schedules, and clinical evidence. Understanding these differences helps you and your prescriber select the most appropriate treatment for your circumstances.

Wegovy contains semaglutide, a GLP-1 receptor agonist that demonstrated average weight loss of 14.9% over 68 weeks in the STEP-1 trial [3]. Administered weekly like Mounjaro, semaglutide works through a single hormone pathway compared to tirzepatide's dual mechanism. Saxenda uses liraglutide, an earlier-generation GLP-1 treatment requiring daily injections, with average weight reductions around 8% in clinical studies [4].

Oral treatments like Orlistat and Xenical work by blocking dietary fat absorption in the intestine, producing more modest weight loss of approximately 5-10% when combined with calorie restriction [5]. These medications suit patients who prefer tablets over injections but require strict adherence to a low-fat diet to minimise gastrointestinal side effects.

Choosing Between Injectable and Oral Options

Your UK prescriber will assess factors including your BMI, previous weight loss attempts, medical conditions like type 2 diabetes, and personal preferences regarding injection frequency. Injectable GLP-1 treatments generally produce greater weight reduction but require comfort with self-administration, whilst oral medications offer convenience with different side effect profiles.

Patients with cardiovascular risk factors may benefit from medications with proven cardioprotective effects demonstrated in dedicated outcome trials. Your clinical assessment ensures treatment selection aligns with both your weight goals and overall health optimisation.

Mounjaro Discount Code and How to Access Treatment

New patients at Cured Pharmacy can apply discount code WEIGHTLOSSNEW during checkout to receive £135.00 off their first Mounjaro prescription. This discount makes starting treatment more affordable whilst maintaining the same rigorous clinical standards and medication quality.

To access Mounjaro through our service, you'll complete a free online consultation taking under three minutes. Our UK-registered prescribers review your medical history, current medications, weight loss goals, and any contraindications. If Mounjaro is clinically appropriate and safe for you, your prescription is issued and dispensed by our GPhC-registered pharmacy team.

Prescription approval is never guaranteed and depends entirely on clinical suitability. Patients with certain medical conditions, those taking specific medications, or individuals outside recommended BMI thresholds may not be suitable candidates. Your prescriber may suggest alternative treatments better suited to your circumstances.

What Happens After Your Consultation

Once your prescription is approved, Mounjaro is dispatched in discreet, temperature-controlled packaging with next-day delivery options available across the UK. You'll receive clear administration instructions, dosing schedules, and guidance on managing potential side effects.

Our clinical team remains available for ongoing support throughout your treatment. Follow-up consultations ensure your dose remains optimised as you progress, and any concerns about tolerability or efficacy are addressed promptly by UK-registered healthcare professionals.

Clinical Evidence: SURPASS and SURMOUNT Trial Results

Tirzepatide's efficacy has been established through the SURPASS and SURMOUNT clinical trial programmes, representing some of the largest weight management studies conducted. SURMOUNT-1 enrolled 2,539 adults with obesity or overweight plus weight-related comorbidities, demonstrating dose-dependent weight reductions ranging from 15% to 22.5% over 72 weeks [1].

The SURPASS-2 trial compared tirzepatide directly against semaglutide 1mg in patients with type 2 diabetes, showing superior weight loss and glycaemic control across all tirzepatide doses [6]. These head-to-head results informed clinical guidelines and prescribing decisions across UK weight management services.

Secondary outcomes across trials included improvements in waist circumference, blood pressure, lipid profiles, and inflammatory markers. Approximately 89-96% of participants on higher tirzepatide doses achieved at least 5% weight loss — the threshold associated with meaningful health benefits — compared to 28% on placebo [1].

Mounjaro Side Effects and Safety Considerations

The most common side effects reported with Mounjaro are gastrointestinal, including nausea (occurring in 20-30% of patients), diarrhoea, vomiting, constipation, and abdominal discomfort [2]. These effects typically emerge during dose escalation phases and diminish as treatment continues, though some patients experience persistent symptoms requiring dose adjustment or treatment discontinuation.

Serious but rare risks include pancreatitis, gallbladder disease, and thyroid C-cell tumours observed in rodent studies (though not confirmed in humans). Mounjaro carries a boxed warning in some jurisdictions regarding thyroid tumours and is contraindicated in patients with personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 [2].

Hypoglycaemia risk increases when Mounjaro is combined with insulin or sulfonylureas, requiring dose adjustments of these medications. Patients should be counselled on recognising hypoglycaemia symptoms and appropriate management. Your UK prescriber will review your complete medication list during consultation to identify and mitigate potential drug interactions.

Mounjaro is not recommended during pregnancy or breastfeeding due to insufficient safety data. Women of childbearing potential should use effective contraception during treatment and discontinue Mounjaro at least two months before planned conception, as advised by MHRA guidance.

Scientific References

1. Jastreboff, A. M., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
2. Medicines and Healthcare products Regulatory Agency. (2023). Mounjaro 2.5 mg solution for injection in pre-filled pen: Summary of Product Characteristics. MHRA. https://products.mhra.gov.uk/ [accessed 13 August 2026]
3. Wilding, J. P. H., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
4. Pi-Sunyer, X., et al. (2015). A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. New England Journal of Medicine, 373(1), 11–22. https://doi.org/10.1056/NEJMoa1411892 [accessed 13 August 2026]
5. National Institute for Health and Care Excellence. (2014). Obesity: identification, assessment and management (CG189). NICE. https://www.nice.org.uk/guidance/cg189 [accessed 13 August 2026]
6. Frías, J. P., et al. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. New England Journal of Medicine, 385(6), 503–515. https://doi.org/10.1056/NEJMoa2107519 [accessed 13 August 2026]
7. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
8. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
9. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary, and weight loss outcomes depend on adherence to treatment, dietary modifications, and physical activity levels.